Implants News and Research

RSS

Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers

Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.

13 Jul 2010

Biomet fourth-quarter net sales increase 10% to $702.5M

Biomet, Inc. announced today financial results for its fourth quarter and fiscal year ended May 31, 2010.

13 Jul 2010

Hip and knee specialist indicates five primary reasons why knee implant fails

While most knee replacements will function well for years, patients should be aware of the signs of failure—including increased pain or decreased function—that may require a corrective procedure known as revision total knee replacement, if necessary.

12 Jul 2010

SurModics to present four scientific posters on drug delivery technologies at CRS Annual Meeting

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, is participating at the 37th Annual Meeting and Exposition of the Controlled Release Society, July 10-14, 2010 in Portland, Oregon (booth #521).

9 Jul 2010

Integra LifeSciences launches DuraGen Plus Dural Regeneration Matrix - Spinal Matrix

Integra LifeSciences Holdings Corporation announced today the launch of DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix, an absorbable and sutureless collagen onlay indicated as a dura substitute for the repair of dura mater.

9 Jul 2010

MEDICREA Group sales increase 32% for first half of 2010

The MEDICREA Group, a specialist in the design, manufacture and sale of spinal implants, is publishing its sales figures for the first half of 2010.

9 Jul 2010

SurModics licenses biodegradable polymer implant technology to Clinuvel

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.

8 Jul 2010

Cardiac Concepts initiates enrollment in European trial of RespiCardia System for CSA

Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.

8 Jul 2010

Modern Plastics adds MediPEEK-IM products

Modern Plastics has added extruded-plate MediPEEK-IM, a permanent implantable medical-grade PEEK (Polyetheretherketone), to its medical-grade plastics offering. MediPEEK-IM is a high-performance semi-crystalline thermoplastic designed for long-term body contact. The resin is produced to ASTM F2026 specifications and has been extensively tested to ISO-10993 requirements.

7 Jul 2010

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Crux Biomedical®Inc. announced today that it has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate the safety and efficacy of Crux's new Vena Cava Filter (VCF). The Crux VCF is a retrievable, implantable filter which is designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). It is the first VCF to be developed that is bidirectional and thus permits insertion or retrieval from either the femoral or jugular veins.

7 Jul 2010

Amedica, SUNY Upstate Medical University partner in comparative study of biomaterials

Amedica Corporation, a spinal and orthopaedic implant and instrument manufacturer focused on unique silicon nitride (SiN) ceramic technologies, announced that it has entered into an agreement with SUNY Upstate Medical University to conduct an additional research study that evaluates the company's SiN ceramic technology compared to PEEK interbody fusion devices. The two-year study will measure the fusion performance of the two biomaterials.

2 Jul 2010

New device could improve conventional cochlear implants

More electrodes and a thinner, more flexible wire inserted further into the inner ear could improve conventional cochlear implants, a team of Medical College of Georgia and Georgia Institute of Technology researchers say.

2 Jul 2010

Researchers uncover potential drug treatment for noise-induced hearing loss

Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.

1 Jul 2010

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

Using advanced 3D/4D ultrasound to guide embryo transfer during in vitro fertilization (IVF) significantly reduces a woman's risk of ectopic pregnancy and its associated complications, Robert Gergely, M.D., medical director, 3D Sonography Center of Beverly Hills, reported today.

30 Jun 2010

AqueSys secures $35 million in Series C financing round

AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.

30 Jun 2010

Biomet fourth-quarter worldwide net sales up 10% to $703 million

Biomet, Inc. announced today fourth quarter and fiscal year 2010 preliminary net sales results for the year ended May 31, 2010.

28 Jun 2010

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retrial of a federal FOSAMAX case, Boles v. Merck. This case was the Plaintiffs' Steering Committee's top choice to take to trial and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX. The first case to reach a verdict, Maley v. Merck, resulted in a defense verdict for Merck on May 5, 2010.

28 Jun 2010

Researchers say ear tubes are safe for children with cochlear implants

Children who are being treated for hearing loss with cochlear implants can safely have ear tubes installed to help clear up infections, say researchers at the University of Alabama at Birmingham (UAB).

25 Jun 2010

Tryton announces first three implants of Side Branch Stent System in Israel

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the company's TRYTON Side Branch Stent™ System has been used in three cases in Israel for the first time.

24 Jun 2010

IsoRay, Hologic complete exclusive worldwide distribution agreement for GliaSite radiation therapy system

IsoRay, Inc. announced today that it has completed a license agreement with Hologic, Inc. for exclusive worldwide distribution rights to the GliaSite® radiation therapy system, the world's only FDA-cleared balloon catheter device used in the treatment of brain cancer. The system's balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.

From Hologic, Inc. 23 Jun 2010

Implants News and Research

Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers

Biomet fourth-quarter net sales increase 10% to $702.5M

Hip and knee specialist indicates five primary reasons why knee implant fails

SurModics to present four scientific posters on drug delivery technologies at CRS Annual Meeting

Integra LifeSciences launches DuraGen Plus Dural Regeneration Matrix - Spinal Matrix

MEDICREA Group sales increase 32% for first half of 2010

SurModics licenses biodegradable polymer implant technology to Clinuvel

Cardiac Concepts initiates enrollment in European trial of RespiCardia System for CSA

Modern Plastics adds MediPEEK-IM products

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Amedica, SUNY Upstate Medical University partner in comparative study of biomaterials

New device could improve conventional cochlear implants

Researchers uncover potential drug treatment for noise-induced hearing loss

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

AqueSys secures $35 million in Series C financing round

Biomet fourth-quarter worldwide net sales up 10% to $703 million

Merck challenges New York jury decision in federal FOSAMAX retrial

Researchers say ear tubes are safe for children with cochlear implants

Tryton announces first three implants of Side Branch Stent System in Israel

IsoRay, Hologic complete exclusive worldwide distribution agreement for GliaSite radiation therapy system

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News